PRC2-Mediated Epigenetic Suppression of Type I IFN-STAT2 Signaling Impairs Antitumor Immunity in Luminal Breast Cancer.

Hong J, Lee JH, Zhang Z, Wu Y, Yang M, Liao Y, de la Rosa R, Scheirer J, Pechacek D, Zhang N, Xu Z, Curiel T, Tan X, Huang TH, Xu K
Cancer Res. 2022 Dec 16;82(24):4624-4640. doi: 10.1158/0008-5472.CAN-22-0736. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.